UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000035957
Receipt number R000040949
Scientific Title Effects of neuromuscular electrical stimulation of quadriceps force and oral administration of branched-chain amino acid in patients after Living-donor liver transplantation
Date of disclosure of the study information 2019/04/01
Last modified on 2019/03/08 10:48:29

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effects of neuromuscular electrical stimulation of quadriceps force and oral administration of branched-chain amino acid in patients after Living-donor liver transplantation

Acronym

Effects of neuromuscular electrical stimulation and branched chain amino acid in patients after Living-donor liver transplantation

Scientific Title

Effects of neuromuscular electrical stimulation of quadriceps force and oral administration of branched-chain amino acid in patients after Living-donor liver transplantation

Scientific Title:Acronym

Effects of neuromuscular electrical stimulation and branched chain amino acid in patients after Living-donor liver transplantation

Region

Japan


Condition

Condition

Patients after Living-donor liver transplantation

Classification by specialty

Hepato-biliary-pancreatic medicine Rehabilitation medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Effects of neuromuscular electrical stimulation and oral administration of branched-chain amino acid on quadriceps force

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Quadriceps force

Key secondary outcomes

An activity of daily living,
Postoperative day


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Historical

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine Device,equipment

Interventions/Control_1

Intervention group:
We used electrical muscle stimulation.
Stimulation region: Quadriceps muscle
Intensity: Symmetrical biphasic square pulsed current at 45 Hz
Pulse: 400 ms
Duty cycle: 12 sec on and 6 sec off
Intensity: 40-80 mA
Time: 45 min 1session 5time per week

BCAA; Aminoleban
Dose frequency; after every meal
administration period; 1 month after LDLT

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

The adult patient that is possible to evaluated in patients of preoperative living doner liver transplantation.
Informed consent was obtained from all
patients prior to participation in the study.

Key exclusion criteria

1) Musculoskeletal impairment
2) Cerebral vascular disorder
3) Severe visually and hearing impairment

Target sample size

40


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Hisamitsu Miyaaki

Organization

Nagasaki University Hospital

Division name

Department of gastroenterology and Hepatology

Zip code


Address

1-7-1 Sakamoto, Nagasaki

TEL

095-819-7481

Email

miyaaki-hi@umin.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Masafumi Haraguchi

Organization

Nagasaki University Hospital

Division name

Department of gastroenterology and Hepatology

Zip code


Address

1-7-1 Sakamoto, Nagasaki

TEL

095-819-7481

Homepage URL


Email

mharaguchi@nagasaki-u.ac.jp


Sponsor or person

Institute

Department of gastroenterology and Hepatology, Nagasaki University Hospital

Institute

Department

Personal name



Funding Source

Organization

Department of gastroenterology and Hepatology, Nagasaki University Hospital

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2019 Year 04 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Terminated

Date of protocol fixation

2019 Year 03 Month 28 Day

Date of IRB


Anticipated trial start date

2019 Year 04 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2019 Year 02 Month 20 Day

Last modified on

2019 Year 03 Month 08 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000040949


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name